Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of 14C-labeled ASP3652 in Healthy Men
NCT02046798Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of asp3652 in chronic prostatitis chronic pelvic pain syndrome (CP/CPPS), sponsored by Astellas Pharma. Primary endpoints: Total radioactivity in plasma, Total radioactivity in whole blood and 7 more. Started Jul 2012; status: completed.
02
Drugs
asp3652
03
Conditions
chronic prostatitis chronic pelvic pain syndrome (CP/CPPS)
Beyond the preview
Go deeper on NCT02046798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046798.